229 related articles for article (PubMed ID: 25083072)
21. Cadherin-catenin adhesion system and mucin expression: a comparison between young and older patients with gastric carcinoma.
Silva EM; Begnami MD; Fregnani JH; Pelosof AG; Zitron C; Montagnini AL; Soares FA
Gastric Cancer; 2008; 11(3):149-59. PubMed ID: 18825309
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of host- and tumor-related factors in patients with gastric cancer.
Hottenrott C; Katsios C
World J Surg; 2010 Oct; 34(10):2496-7; author reply 2498. PubMed ID: 20376446
[No Abstract] [Full Text] [Related]
23. TMEM16A overexpression contributes to tumor invasion and poor prognosis of human gastric cancer through TGF-β signaling.
Liu F; Cao QH; Lu DJ; Luo B; Lu XF; Luo RC; Wang XG
Oncotarget; 2015 May; 6(13):11585-99. PubMed ID: 25839162
[TBL] [Abstract][Full Text] [Related]
24. Methylation-mediated gene silencing as biomarkers of gastric cancer: a review.
Nakamura J; Tanaka T; Kitajima Y; Noshiro H; Miyazaki K
World J Gastroenterol; 2014 Sep; 20(34):11991-2006. PubMed ID: 25232236
[TBL] [Abstract][Full Text] [Related]
25. MiRNA as potential biomarkers and therapeutic targets for gastric cancer.
Shin VY; Chu KM
World J Gastroenterol; 2014 Aug; 20(30):10432-9. PubMed ID: 25132759
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of PCDHB9 promotes peritoneal metastasis and correlates with poor prognosis in patients with gastric cancer.
Mukai S; Oue N; Oshima T; Imai T; Sekino Y; Honma R; Sakamoto N; Sentani K; Kuniyasu H; Egi H; Tanabe K; Yoshida K; Ohdan H; Yasui W
J Pathol; 2017 Sep; 243(1):100-110. PubMed ID: 28671736
[TBL] [Abstract][Full Text] [Related]
27. Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer.
Ryu HS; Park DJ; Kim HH; Kim WH; Lee HS
Hum Pathol; 2012 Apr; 43(4):520-8. PubMed ID: 22018628
[TBL] [Abstract][Full Text] [Related]
28. Proteomic and metabolic prediction of response to therapy in gastric cancer.
Aichler M; Luber B; Lordick F; Walch A
World J Gastroenterol; 2014 Oct; 20(38):13648-57. PubMed ID: 25320503
[TBL] [Abstract][Full Text] [Related]
29. Biomarkers for gastric cancer: prognostic, predictive or targets of therapy?
Durães C; Almeida GM; Seruca R; Oliveira C; Carneiro F
Virchows Arch; 2014 Mar; 464(3):367-78. PubMed ID: 24487788
[TBL] [Abstract][Full Text] [Related]
30. Microsatellite Instability and Altered Expressions of MLH1 and MSH2 in Gastric Cancer.
Haron NH; Mohamad Hanif EA; Abdul Manaf MR; Yaakub JA; Harun R; Mohamed R; Mohamed Rose I
Asian Pac J Cancer Prev; 2019 Feb; 20(2):509-517. PubMed ID: 30803214
[TBL] [Abstract][Full Text] [Related]
31. Circular RNAs in Gastric Cancer: Potential Biomarkers and Therapeutic Targets.
Ouyang J; Long Z; Li G
Biomed Res Int; 2020; 2020():2790679. PubMed ID: 32685459
[TBL] [Abstract][Full Text] [Related]
32. Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?
Singh SS; Yap WN; Arfuso F; Kar S; Wang C; Cai W; Dharmarajan AM; Sethi G; Kumar AP
World J Gastroenterol; 2015 Nov; 21(43):12261-73. PubMed ID: 26604635
[TBL] [Abstract][Full Text] [Related]
33. What Will We Expect From Novel Therapies to Esophageal and Gastric Malignancies?
De Mello RA; Castelo-Branco L; Castelo-Branco P; Pozza DH; Vermeulen L; Palacio S; Salzberg M; Lockhart AC
Am Soc Clin Oncol Educ Book; 2018 May; 38():249-261. PubMed ID: 30231398
[TBL] [Abstract][Full Text] [Related]
34. MicroRNAs as potential biomarkers for gastric cancer.
Liu HS; Xiao HS
World J Gastroenterol; 2014 Sep; 20(34):12007-17. PubMed ID: 25232237
[TBL] [Abstract][Full Text] [Related]
35. GM130 regulates epithelial-to-mesenchymal transition and invasion of gastric cancer cells via snail.
Zhao J; Yang C; Guo S; Wu Y
Int J Clin Exp Pathol; 2015; 8(9):10784-91. PubMed ID: 26617790
[TBL] [Abstract][Full Text] [Related]
36. Stem cells in gastric cancer.
Zhao Y; Feng F; Zhou YN
World J Gastroenterol; 2015 Jan; 21(1):112-23. PubMed ID: 25574084
[TBL] [Abstract][Full Text] [Related]
37. Recent advances in the molecular diagnostics of gastric cancer.
Kanda M; Kodera Y
World J Gastroenterol; 2015 Sep; 21(34):9838-52. PubMed ID: 26379391
[TBL] [Abstract][Full Text] [Related]
38. MicroRNAs: promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential.
Matuszcak C; Haier J; Hummel R; Lindner K
World J Gastroenterol; 2014 Oct; 20(38):13658-66. PubMed ID: 25320504
[TBL] [Abstract][Full Text] [Related]
39. Molecular biology of gastric cancer.
Cervantes A; Rodríguez Braun E; Pérez Fidalgo A; Chirivella González I
Clin Transl Oncol; 2007 Apr; 9(4):208-15. PubMed ID: 17462972
[TBL] [Abstract][Full Text] [Related]
40. LncRNAs as potential diagnostic and prognostic biomarkers in gastric cancer: A novel approach to personalized medicine.
Fattahi S; Kosari-Monfared M; Golpour M; Emami Z; Ghasemiyan M; Nouri M; Akhavan-Niaki H
J Cell Physiol; 2020 Apr; 235(4):3189-3206. PubMed ID: 31595495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]